biotech / news / / The Manila Times
Traws Pharma is responding to the threat of Hantavirus, a rodent-borne negative-strand RNA virus.
Traws Pharma is advancing clinical candidates specifically for the treatment of hantavirus infections.
KEY POINTS
- Recent cruise ship fatalities and illnesses have been linked to a hantavirus outbreak.
- Traws' antiviral candidates have previously demonstrated inhibition of negative-strand virus replication.
- No approved treatments exist for Hantaan pulmonary disease, highlighting the urgent need for new therapies.
COMPANIES
Summarized by Newsio from The Manila Times. How we summarize →